<html lang="en">

<head>
  <title>Pediatric Bronchiolitis</title>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1.0" />
  <link rel="stylesheet" href="cpgPedEr.css" />
</head>

<body>
  <div id="header-container"></div>
  <header class="page-header">Acute Bronchiolitis</header>

  <div class="container">
    <p class="cpg-headers">DEFINITION</p>
    <p class="cpg-text">An acute inflammation leading to edema, necrosis of epithelial cells lining of small airways,
      and increased mucus production caused mainly by viruses </p>
    <div class="border-btm"></div>

    <p class="cpg-headers">SIGNS AND SYMPTOMS</p>
    <p class="cpg-text">Typically begin with rhinitis and cough, which may progress to tachypnea, wheezing, rales, use
      of accessory muscles, and/or nasal flaring</p>
    <div class="border-btm"></div>

    <p class="cpg-headers">CAUSES</p>
    <ol>
      <li>Viruses mainly <b>respiratory syncytial virus (RSV)</b> (50-70% of cases)</li>
      <li>Highest incidence between December and March (North America)</li>
      <li><b>90%</b> of children are infected with RSV in the first 2 years of life</li>
      <li>40% experience lower respiratory tract infection during the initial infection</li>
      <li>Infection with RSV does not grant permanent or long-term immunity</li>
    </ol>

    <div class="border-btm"></div>

    <p class="cpg-headers">RISK FACTORS FOR SEVERE DISEASE</p>
    <ol>
      <li>Age less than 12 weeks</li>
      <li>History of prematurity</li>
      <li>Underlying cardiopulmonary disease, or immunodeficiency</li>
    </ol>
    <div class="border-btm"></div>

    <p class="cpg-headers">INVESTIGATIONS</p>
    <ul>
      <li>Outpatient</li>
      <ul>
        <li>In most outpatient cases no need for investigations</li>
      </ul>
      <li>Inpatients</li>

      <ul>
        <li>CBC: WBC count and differential help if bacterial infection is suspected</li>
        <li>Electrolytes and kidney function: help in dehydration management and if there is hyponatremia either
          iatrogenic or due to excessive releases of antidiuretic hormone</li>
        <li><b>CXR:</b> not indicated in all cases (Strength: Strong, Quality: B)</li>
      </ul>
    </ul>
    <div class="border-btm"></div>

    <p class="cpg-headers">TREATMENT</p>
    <p class="cpg-headers">Recommended</p>
    <ul>
      <li><b>Fluids (IV or NG)</b></li>
      <ul>
        <li>Initial bolus if there is dehydration</li>
        <li>Full maintenance if the patient NPO due to distress and tachypnea</li>
        <li>Supplementary fluids if the patient not taking enough oral intake</li>
      </ul>
      <li><b>Oxygen</b></li>
      <ul>
        <li>To keep saturation above 90%</li>
        <li>In moderate to severe cases use high flow nasal canula</li>
        <li>Adjust flow rate to keep saturation 90-92%</li>
        <li>Use flow of 1-2 Liter/kg/minute with a maximum of 12L/minute</li>
      </ul>
      <li><b>Nasal suctioning</b></li>
      <ul>
        <li>Provides relief of distress or cyanosis</li>
        <li>most beneficial before feeding and in response to copious secretions</li>
        <li>No evidence exists to support deep suctioning of the lower pharynx.</li>
        <li>excessive suction can be associated with nasal edema and lead to additional obstruction</li>
      </ul>
    </ul>

    <p class="cpg-headers">Not to be Used</p>
    <ul>
      <li><b>Salbutamol (Strength: Strong, Quality: B)</b></li>
      <ul>
        <li>Should not be used in patients with isolated acute bronchiolitis.</li>
        <li>One trial of salbutamol can be used</li>
        <li>If the patient showed signs of improvement (decrease respiratory rate, improved saturation, decreased
          wheezes) it can be continued</li>
        <li>Bronchodilators even if they cause the above improvements, they will not affect the disease course, length
          of stay, or oxygen need </li>
        <li>If the patient didn't improve after the first trial. salbutamol should be stopped</li>
      </ul>
      <li><b>Nebulized epinephrine </b>should not be used (Strength: Strong, Quality: B)</li>
      <li><b>Nebulized hypertonic saline</b></li>

      <ul>
        <li>Should not be administered in the emergency department (Strength: Moderate, Quality: B)</li>
        <li>Its effectiveness after admission is inconsistent</li>
        <li>It can be used in cases of atelectasis

        </li>
        <li>It can cause severe cough in some patients</li>
      </ul>
      <li><b>Chest Physiotherapy</b> should not be used routinely (atelectasis excluded)</li>
      <li><b>Antibiotics</b> should not be used unless there is a concomitant bacterial infection, or a strong suspicion
        of one</li>
    </ul>

    <p class="cpg-headers">CONTRAINDICATED</p>
    <ul>
      <li>Clinicians should not administer systemic <b>corticosteroids</b> to infants with a diagnosis of acute
        bronchiolitis in any setting (Strength: Strong, Quality: A)</li>

      <li><b>Sedatives (antihistamines)</b> can lead to sedation and more hypoxia</li>
      <li><b>Nasal decongestant</b> drops no evidence supports the use of such medications </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">INFECTION CONTROL</p>
    <ul>
      <li>Disinfect hands before and after direct contact with patient or his/her objects</li>

      <li>Use alcohol-based rubs</li>
    </ul>

  </div>
  <script src="/PedRef/js/header.js"></script>
</body>

</html>
